Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lassen., Ulrik V."'
Autor:
Hasselbalch, Benedikte, Eriksen, Jesper Grau, Broholm, Helle, Christensen, Ib Jarle, Grunnet, Kirsten, Horsman, Michael Robert, Poulsen, Hans Skovgaard, Stockhausen, Marie-Thérése, Lassen, Ulrik V
Publikováno v:
Hasselbalch, B, Eriksen, J G, Broholm, H, Christensen, I J, Grunnet, K, Horsman, M R, Poulsen, H S, Stockhausen, M-T & Lassen, U 2010, ' Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan ', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 118, no. 8, pp. 585-94 . https://doi.org/10.1111/j.1600-0463.2010.02631.x
Hasselbalch, B, Eriksen, J G, Broholm, H, Christensen, I J, Grunnet, K, Horsman, M R, Poulsen, H S, Stockhausen, M-T & Lassen, U V 2010, ' Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan ', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 118, no. 8, pp. 585-94 . https://doi.org/10.1111/j.1600-0463.2010.02631.x
Hasselbalch, B, Eriksen, J G, Broholm, H, Christensen, I J, Grunnet, K, Horsman, M R, Poulsen, H S, Stockhausen, M-T & Lassen, U V 2010, ' Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan ', Acta Pathologica Microbiologica et Immunologica Scandinavica, vol. 118, no. 8, pp. 585-94 . https://doi.org/10.1111/j.1600-0463.2010.02631.x
Several recent studies have demonstrated a beneficial effect of anti-angiogenic treatment with the vascular endothelial growth factor-neutralizing antibody bevacizumab in recurrent high-grade glioma. In the current study, immunohistochemical evaluati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2265492795951b209e9e3daa1263b4ab
https://pure.au.dk/portal/da/publications/prospective-evaluation-of-angiogenic-hypoxic-and-egfrrelated-biomarkers-in-recurrent-glioblastoma-multiforme-treated-with-cetuximab-bevacizumab-and-irinotecan(7e037243-138c-4fa2-8e40-2c4b77e378c2).html
https://pure.au.dk/portal/da/publications/prospective-evaluation-of-angiogenic-hypoxic-and-egfrrelated-biomarkers-in-recurrent-glioblastoma-multiforme-treated-with-cetuximab-bevacizumab-and-irinotecan(7e037243-138c-4fa2-8e40-2c4b77e378c2).html
Autor:
Crone, Christian, Lassen., Ulrik V.
Publikováno v:
Acta Pharmacologica et Toxicologica; 1956, Vol. 12 Issue 4, p342-345, 4p
Autor:
Crone, Christian, Lassen., Ulrik V.
Publikováno v:
Acta Pharmacologica et Toxicologica; 1956, Vol. 12 Issue 4, p338-341, 4p
Autor:
Crone, Christian, Lassen, Ulrik V.
Publikováno v:
Acta Pharmacologica et Toxicologica; 1955, Vol. 11 Issue 4, p362-366, 5p
Autor:
Crone, Christian, Lassen, Ulrik V.
Publikováno v:
Acta Pharmacologica et Toxicologica; 1955, Vol. 11 Issue 4, p355-361, 7p
Autor:
Crone, Christian, Lassen, Ulrik V.
Publikováno v:
Acta Pharmacologica et Toxicologica; 1955, Vol. 11 Issue 3, p295-300, 6p
Autor:
Crone, Christian, Lassen, Ulrik V.
Publikováno v:
Acta Pharmacologica et Toxicologica; 1955, Vol. 11 Issue 3, p301-306, 6p
Autor:
Lassen, Ulrik V., Sagild, Uffe
Publikováno v:
Acta Medica Scandinavica; 1961, Vol. 168 Issue 1, p65-70, 6p
Autor:
Lassen, Ulrik V., Csáky, T. Z.
Publikováno v:
The Journal of General Physiology; May 1966, Vol. 49 Issue: 5 p1029-1041, 13p
Publikováno v:
Nature; 8/15/1959, Vol. 184 Issue 4685, p553-554, 2p